Secreted Lymphotoxin-{alpha} Is Essential for the Control of an Intracellular Bacterial Infection

Daniel R. Roacha, Helen Briscoeb, Bernardette Saundersa, Malcolm P. Francec, Sean Rimintona, and Warwick J. Brittona,b
a Centenary Institute of Cancer Medicine and Cell Biology, Newtown NSW 2042, Australia
b Department of Medicine, University of Sydney, Sydney NSW 2006, Australia
c Department of Veterinary Pathology, University of Sydney, Sydney NSW 2006, Australia

Correspondence to: Warwick J. Britton, Centenary Institute of Cancer Medicine and Cell Biology, Locked Bag No. 6, Newtown NSW 2042, Australia. Tel:61-2-9515-5210 Fax:61-2-9351-3968 E-mail:wbritton{at}medicine.usyd.edu.au.


  Abstract
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
References

Although the essential role of tumor necrosis factor (TNF) in the control of intracellular bac-terial infection is well established, it is uncertain whether the related cytokines lymphotoxin-{alpha} (LT{alpha}3) and lymphotoxin-ß (LTß) have independent roles in this process. Using C57Bl/6 mice in which the genes for these cytokines have been disrupted, we have examined the relative contribution of secreted LT{alpha}3 and membrane-bound LTß in the host response to aerosol Mycobacterium tuberculosis infection. To overcome the lack of peripheral lymph nodes in LT{alpha}-/- and LTß-/- mice, bone marrow chimeric mice were constructed. LT{alpha}-/- chimeras, which lack both secreted LT{alpha}3 and membrane-bound LTß (LT{alpha}1ß2 and LT{alpha}2ß1), were highly susceptible and succumbed 5 wk after infection. LTß-/- chimeras, which lack only the membrane-bound LTß, controlled the infection in a comparable manner to wild-type (WT) chimeric mice. T cell responses to mycobacterial antigens and macrophage responses in LT{alpha}-/- chimeras were equivalent to those of WT chimeras, but in LT{alpha}-/- chimeras, granuloma formation was abnormal. LT{alpha}-/- chimeras recruited normal numbers of T cells into their lungs, but the lymphocytes were restricted to perivascular and peribronchial areas and were not colocated with macrophages in granulomas. Therefore, LT{alpha}3 is essential for the control of pulmonary tuberculosis, and its critical role lies not in the activation of T cells and macrophages per se but in the local organization of the granulomatous response.

Key Words: lymphotoxin, TNF, tuberculosis, granuloma, lung


  Introduction
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
References

The control of chronic intracellular bacterial infection is dependent on the activation and expression of cellular immunity (1). In the case of Mycobacterium tuberculosis infection, infected APCs activate T cells in the context of IL-12, leading to a Th1 pattern of T cell responses. Mycobacteria-specific T cells are recruited back to the initial site of infection in the lung (2), where they initiate the cascade of cellular and molecular events that control the infection. The expression of immunity requires the continued recruitment of T cells and macrophages into the lung, the migration and aggregation of these cells to form granulomatous lesions, and the release of IFN-{gamma} by T cells (3), which in concert with TNF activate mycobactericidal mechanisms in infected macrophages (4). Granulomatous lesions are the hallmark of the inflammatory response to mycobacteria and are essential to control infection (1). The cytokine and chemokine signals modulating this inflammatory response are poorly understood, although TNF plays a critical role in orchestrating the movement of these cells once they enter infected tissues (5).

Lymphotoxin (LT) comprises two members of the TNF superfamily, LT{alpha} and LTß. LT{alpha} is active as a secreted homotrimeric molecule (LT{alpha}3, also known as TNF-ß) (6), which binds not only to both of the TNF receptors (TNFRI and TNFRII) (7) (8) but also to the newly identified herpes virus entry mediator (HVEM) receptor (9). In comparison to TNF, which is produced by a wide range of cell types, LT{alpha}3 is produced primarily by CD4+ T cells, B cells, and NK cells (10). As LT{alpha}3 and TNF bind to TNFRI with similar affinity (11) and have ~30% homology in amino acid sequence (12), the functional activity for LT{alpha}3 independent of TNF has been unclear. By contrast, LTß is a heterotrimeric molecule that exists in two forms, the major being LT{alpha}1ß2 and the minor LT{alpha}2ß1 (13). Both forms of LTß bind the unique LTß receptor (LTßR) (14), and LTß signaling through LTßR is essential for the formation of the peripheral lymphoid organs (15). Mice deficient in either LTß or LTßR lack peripheral lymph nodes and Peyer's patches and display disorganized splenic architecture.

Recently, the activity of LT{alpha}3 during immune responses has been reexamined. Transgenic expression of the LT{alpha} gene under control of the rat insulin promoter led to the formation of chronic inflammatory lesions at the sites of transgene expression (16). These lesions resembled secondary lymphoid tissue, not only in their cellular composition and structure, but also in their ability to respond to Ag. Interestingly, TNFRI was the receptor mediating the formation of these lesions. LT{alpha}- and LTß-deficient mice have also been employed to investigate the independent functions of LT{alpha}3 and LTß in inflammatory pathologies. Targeted disruption of the gene for LT{alpha} results in loss of both secreted LT{alpha}3 and cell surface LTß complexes, whereas targeted disruption of the LTß gene results in loss of only cell surface LTß. Disruption of either LT{alpha} or LTß also results in the phenotypic loss of secondary lymphoid tissue. Using radiation bone marrow chimeras with gene-targeted and wild-type (WT) animals, normal secondary lymphoid organ function has been reconstituted, enabling the study of cytokine effector function at the target tissue level (17). In this manner, LT{alpha}3 was shown to have no independent role in the cellular inflammation or clinical course of experimental autoimmune encephalomyelitis (EAE), a model of tissue-specific autoimmune disease (17).

To determine whether LT{alpha}3 or LTß independently contribute to the host response to M. tuberculosis infection, we have constructed radiation bone marrow chimeras, using as donors C57Bl/6 mice in which the genes for LT{alpha} or LTß have been disrupted. Transfer of bone marrow into irradiated mice resulted in repopulation of peripheral lymphoid tissues with leukocytes deficient in both LT{alpha}3 and LTß or deficient in LTß alone. Analysis of low dose aerosol M. tuberculosis infection in these mice demonstrated the essential role of LT{alpha}3 in the host response to mycobacterial infection. Although there was evidence of induction of Ag-specific T cell responses and activation of macrophages, mycobacterial growth was unrestrained, leading to the death of LT{alpha}-/- chimeric mice. By contrast, LTß-/- chimeric mice were able to control the infection normally. The inflammatory response in the lungs of LT{alpha}-/- chimeric mice was markedly abnormal, with failure to form distinct granulomas, indicating that LT{alpha}3 has an essential role in the cellular recruitment and organization underlying this process.


  Materials and Methods
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
References

Mice.
C57Bl/6 (Ly5.2), C57Bl/6.Ly5.1, and C57Bl/6.RAG-1-/- mice were obtained from Animal Resources Centre, and LT{alpha} and LTß gene knockout mice on a C57BL/6 background have been previously described (17) (18). Adult (>6 wk old) mice were used in all experiments. Mice were housed under specific pathogen–free conditions at the Centenary Institute animal facility, or after infection in a Level 3 physical containment facility.

Generation of Radiation Bone Marrow Chimeras.
Radiation bone marrow chimeric mice were generated as in Riminton et al. (17). To monitor engraftment, C57Bl/6.Ly5.1 bone marrow was transferred into C57Bl/6.Ly5.2 recipient mice. Peripheral blood was analyzed by flow cytometry for the presence of the Ly5.1 congenic marker, and reconstitution was considered satisfactory when >95% of leukocytes were of donor type.

Aerosol Infection of Mice with M. tuberculosis.
A Middlebrook airborne infection apparatus (Glas-Col Inc.) delivered ~100 bacilli of M. tuberculosis H37Rv (American Type Culture Collection no. 27294) to each mouse. The number of viable bacteria in target organs was determined by plating serial dilutions of organ homogenates on supplemented Middlebrook 7H11 nutrient agar (Difco Labs.). The data are expressed as the log10 of the mean number of bacteria recovered per organ.

Lung Preparations.
Mice were killed at several time points after aerosol M. tuberculosis infection. One lung was homogenized and serial dilutions spread on duplicate quadrants of bacterial plates. The other lung was minced and incubated with collagenase (10 U/ml; Worthington) and DNase (13 µg/ml; Boehringer Mannheim) to produce a cell suspension, as previously described (5).

Phenotypic Analysis of Pulmonary Infiltrates.
mAbs used for flow cytometry were: CD4 (CT-CD4; Caltag Laboratories), CD8 (CT-CD8; Caltag Laboratories), CD16/32 (2.4G2; BD PharMingen), CD44 (IM 7.8.1; Sigma-Aldrich), CD45RB (16A; Sigma-Aldrich), Ly-6G (RB6-8C5; BD PharMingen), biotinylated anti-Ly5.1, and streptavidin–PE (Sigma-Aldrich).

T Cell Responses to Mycobacterial Ags.
Mediastinal lymph node or lung cell suspensions were suspended in culture medium (RPMI-1640; Sigma-Aldrich), 10% FCS (CSL Bioscience), 2 mM L-glutamine (Flow Laboratories), 50 mM 2-ME (Sigma-Aldrich), 10 mM HEPES (Sigma-Aldrich), and 10 mM sodium bicarbonate (BDH) and cultured alone or with purified protein derivative (PPD; 10 µg/ml) of M. tuberculosis (Statens Seruminstitut) for 72 h, and total IFN-{gamma} production was measured by capture ELISA (5). The frequency of IFN-{gamma}–producing cells was determined by ELISpot assay, as previously described (5). Delayed-type hypersensitivity (DTH) reactions were determined as the difference in swelling between PBS-injected footpads and PPD-injected footpads, as described in reference (5).

Generation of Bone Marrow–derived Macrophages.
Macrophages were derived from bone marrow by culture in medium supplemented with 20% L929 fibroblast culture supernatant for 7 d at 37°C. Cells were stimulated with LPS (10 µg/ml; Sigma-Aldrich) and IFN-{gamma} (100 U/ml; Boehringer Mannheim) for 72 h. In infection studies, cells were prestimulated with IFN-{gamma} (100 U/ml) or culture medium for 16 h and infected with M. tuberculosis H37Rv (multiplicity of infection 1:1), and the supernatants were harvested after 54 h.

Nitrite Measurements.
Serum nitrite was obtained by reducing serum nitrate to nitrite with nitrate reductase, and the nitrite concentrations in culture supernatants levels were determined using the Greiss reagent (reference (19); 3% phosphoric acid, 1% p-aminobenzene-sulphonamide, 1% n-1-napthylethylenediamide; Sigma-Aldrich).

Measurement of Bioactive TNF and Analysis of TNF mRNA by Reverse Transcriptase PCR.
Levels of biologically active TNF were measured using the WEHI 164 cytotoxicity assay (31). For analysis of TNF mRNA, total lung RNA was prepared from 3 wk postinfection–perfused lungs using RNAzol B (Tel-Test). cDNA was synthesized using SUPERSCRIPT II RNase H reverse transcriptase (RT; GIBCO BRL) and analyzed by RT-PCR using primers and methods as previously described (17).

Histological and Immunohistochemical Analysis.
Lung and liver tissues were fixed in 10% neutral buffered formalin, embedded in paraffin blocks, sectioned at 4 µm, and stained with hematoxylin and eosin. Coded slides were assessed blind on 37 criteria for differences in cellular infiltrate. A granuloma in the peripheral lung was defined as a collection of 10 or more macrophages and T lymphocytes.

Statistical Analysis.
Differences between the mean number of CFUs, number of granulocytes, and levels of nitrite and TNF were analyzed by Student's t tests.


  Results
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
References

LT{alpha}- and LTß-deficient Chimeric Mice Generate Normal T Cell Responses after M. tuberculosis Infection.
To confirm the immune competence of the chimeric mice, their ability to mount comparable mycobacterial Ag-specific T cell responses after aerosol M. tuberculosis infection was examined. Mediastinal lymph node cells from all chimeric groups produced significant and comparable amounts of IFN-{gamma} after both PPD stimulation (Fig 1 A) and mitogenic stimulation (data not shown). The frequency of Ag-specific IFN-{gamma}–producing cells in both the lymph nodes and lungs of chimeric mice was also analyzed. All chimeric mice had comparable numbers of IFN-{gamma}–producing cells both in the lungs (Fig 1 B) and in the draining lymph nodes (data not shown). The ability of the chimeric mice to mount Ag-specific DTH reactions was measured at 4 wk after infection. Chimeric mice were challenged with 10 µg of PPD in one footpad and the vehicle control in the other. Chimeric mice from all groups mounted similar DTH responses to mycobacterial proteins (Fig 1 C). Therefore, the deficiencies in either soluble or membrane forms of LT do not affect the potential of these chimeric mice to mount Ag-specific T cell responses after infection with M. tuberculosis.



View larger version (22K):
[in this window]
[in a new window]
 
Figure 1. LT{alpha}-/- chimeric mice have the potential to mount normal T cell responses. (A) Mediastinal lymph node cells from chimeric mice, 3 wk after M. tuberculosis infection, were cultured in vitro in the presence of PPD or PBS for 72 h, and IFN-{gamma} was measured in supernatants by ELISA. The data represent the means and SD of triplicate culture from four mice. (B) Lung cell homogenates from 3 wk infected chimeric mice were cultured overnight in the presence of PPD or PBS, and the frequencies of IFN-{gamma}–producing cells were analyzed by ELISpot assay. The data represent means and SD of triplicate cultures from four mice. (C) The ability of the chimeric mice to mount DTH responses was examined. Chimeric mice were challenged in left hind footpad with 10 µg of PPD and the right hind footpad with PBS on day 28 after infection. The data represent the means and SD of the differences in footpad swelling between the PBS- and PPD-challenged footpad for each of four mice.

LT{alpha}-deficient Chimeras Rapidly Succumb to Aerosol Tuberculosis.
Chimeric mice and normal unmanipulated WT mice were infected with virulent M. tuberculosis, and their clinical condition and bacterial growth was monitored over time. LT{alpha}-/- chimeras appeared healthy to day 28 but then rapidly deteriorated, and all succumbed by day 38 (Fig 2 A). By contrast, both WT and LTß-/- chimeras controlled the same infectious dose and survived for >150 d. The number of mycobacteria recovered from the lungs of LT{alpha}-/- chimeras was comparable to that in WT chimeras for the first 3 wk of infection but was significantly increased from this time. At the time of death, there were 3log10 more bacteria in the lungs of LT{alpha}-/- chimeras compared with WT chimeras (Fig 2 B; P < 0.0001). In contrast, LTß-/- chimeras had comparable bacterial loads in the lungs to WT chimeras over the course of the infection. There was also increased dissemination of organisms into the spleens (Fig 2 C) and livers (Fig 2 D) of LT{alpha}-/-, but not LTß-/-, chimeras compared with WT chimeras. M. tuberculosis–infected control WT chimeric mice and normal WT mice showed comparable rates of survival and bacterial loads (data not shown).



View larger version (26K):
[in this window]
[in a new window]
 
Figure 2. LT{alpha}-/- chimeric, unlike LTß-/- chimeric mice, cannot control M. tuberculosis infection. (A) LT{alpha}-/- chimeric mice (n = 13; {circ}), LTß-/- chimeric mice (n = 15; •) and WT chimeric mice (n = 15; {square}) were exposed to a low dose aerosol of M. tuberculosis and survival monitored over time. Unmanipulated WT mice showed 100% survival (data not shown). The numbers of viable bacteria present in lungs (B), spleen (C), and liver (D) of WT chimeras ({square}), LT{alpha}-/- chimeras ({circ}), and LTß-/- chimeras (•) were determined over time. The data represent the means and SD of the mycobacterial CFUs from four or five mice per time point. These data are representative results from one of two similar experiments (**P < 0.0001).

Recruitment of Leukocytes in Chimeric Mice.
The recruitment of leukocytes to the sites of infection is a critical event in the host response to tuberculosis. Therefore, the numbers of different lymphocyte subpopulations in the lungs were assessed over the course of infection. Comparable numbers of CD4+ (Table 1) and CD8+ (data not shown) T cells were recruited into the lungs of LT{alpha}-/-, LTß-/-, and WT chimeric mice over the course of infection. Similar numbers of B lymphocytes were also observed (data not shown). To investigate the activation state of these T cells, the expression of CD44 and CD45RB was examined on CD4+ T cells. CD4+ T cells from LT{alpha}-/-, LTß-/-, and WT chimeric mice expressed similar levels of CD44highCD45RBlow expression (data not shown). Interestingly, the numbers of granulocytes (Ly-6G+ cells) recruited to the lungs of the chimeric mice differed. At 4 wk after infection, there were significantly more granulocytes (P < 0.005) in the lungs of LT{alpha}-/- chimeric mice compared with both WT and LTß-/- chimeric mice (Table 1).


 
View this table:
[in this window]
[in a new window]
 
Table 1. Recruitment of CD4+ T Cells and Granulocytes (Ly6-G+) to the Lungs of LT{alpha}2/-, LTß2/-, and WT Chimeras after Infection with M. tuberculosis

LT{alpha}-deficient Chimeric Mice Produce Normal Amounts of Reactive Nitrogen Intermediates.
The antimicrobial mechanisms of activated mouse macrophages include the production of reactive nitrogen intermediates (RNI). Therefore, nitrite levels in the sera of the chimeric mice were analyzed throughout the course of infection to determine if LT{alpha}3 plays a critical role in regulating this antimicrobial mechanism. LT{alpha}-/-, LTß-/-, and WT chimeric mice all had similar levels of serum nitrite (Fig 3 A). To determine if macrophages deficient in LT{alpha} and LTß have the potential to produce comparable amounts of RNI to WT macrophages, bone marrow–derived macrophages from the three types of mice were generated. These macrophages were stimulated with LPS and IFN-{gamma} or were infected with M. tuberculosis, with and without pre-stimulation with IFN-{gamma} (Fig 3 B). Macrophages derived from LT{alpha}-/- and LTß-/- bone marrow produced amounts of RNI comparable to those of WT macrophages.



View larger version (45K):
[in this window]
[in a new window]
 
Figure 3. LT{alpha} and LTß are not essential for the host production of RNI, and their deficiency does not affect the potential to produce TNF. (A) The nitrite concentrations in the sera of WT ({square}), LT{alpha}-/- ({circ}), and LTß-/- (•) chimeric mice were analyzed throughout the course of infection. Serum nitrate was reduced to nitrite and nitrite levels determined using the Greiss reagent. The data represents the means and SD of nitrite levels for four or five mice (*P < 0.05). (B) Bone marrow–derived macrophages were stimulated either with medium alone (open column) or LPS (10 µg/ml) and IFN-{gamma} (100 U/ml) (stippled column), or infected with M. tuberculosis with (black column) and without (hatched column) prestimulation with IFN-{gamma} (100 U/ml). Nitrite levels in culture supernatants were determined by the Greiss reagent. The data represents the means and SD for triplicate cultures. (C) TNF mRNA expression in the lungs of chimeric mice 3 wk after infection. RNA was extracted from lung homogenates, and cDNA was synthesized for RT-PCR as described in Materials and Methods. Lane 1, WT chimera; lane 2, LT{alpha}-/- chimera; lane 3, LTß-/- chimera; lane 4, WT control. ß-actin PCR product, 304 bases; TNF PCR product, 256 bases. (D) Bone marrow–derived macrophages were stimulated with either medium alone (open column) or LPS (10 µg/ml) and IFN-{gamma} (100 U/ml) (stippled column) or infected with M. tuberculosis with (black column) and without (hatched column) prestimulation with IFN-{gamma} (100 U/ml). TNF production was measured using the WEHI 164 cytotoxicity assay. The data represent the means and SD for triplicate cultures.

TNF mRNA Expression and TNF Production by Macrophages Is Normal in LT{alpha}-deficient Mice.
To exclude the possibility that the failure of LT{alpha}-/- chimeric mice to control infection was due to a reduced production of TNF, both the expression of mRNA for TNF during infection of chimeric mice and the production of TNF by LT{alpha}-/- and LTß-/- macrophages were examined. Comparable levels of TNF mRNA was expressed in the lungs of LT{alpha}-/-, LTß-/-, and WT chimeric mice during infection (Fig 3 C). Macrophages derived from LT{alpha}-/-, LTß-/-, and WT mice produced similar amounts of TNF after either stimulation with LPS and IFN-{gamma} or infection with M. tuberculosis after prestimulation with IFN-{gamma} (Fig 3 D).

Granulomatous Response in LT{alpha}-deficient Chimeric Mice.
The lungs of the different chimeric mice were examined histologically to determine whether the rate of development and pattern of cellular responses differed across the groups of chimeric mice. In WT chimeras and LTß-/- chimeric mice, the granulomatous response resembled that seen in normal WT mice after aerosol tuberculosis, so that by 4 wk after infection the granulomas in these groups were 0.4–0.8 mm in diameter (Fig 4A and Fig C). These granulomas consisted of intact macrophages, some lymphocytes, and only occasional neutrophils, with no necrosis (Fig 4D and Fig F). The lesions that formed in the lungs of LT{alpha}-/- chimeric mice were markedly different. The peripheral lung lesions had twice the diameter (Fig 4 B) and consisted of collections of neutrophils and fewer macrophages than WT chimeric mice (Fig 4 E). Lymphocytes were absent from the lesions (Fig 4 E), and a moderate amount of necrosis was evident. In contrast to WT and LTß-/- chimeras, the lymphocytes in LT{alpha}-/- chimeras were restricted to perivascular and peribronchial regions (Fig 4 E). This pattern was confirmed by immunohistochemical identification of the lymphocytes with anti-CD3 staining (data not shown).



View larger version (127K):
[in this window]
[in a new window]
 
Figure 4. LT{alpha}-/- chimeric mice have defective granuloma formation. Lung tissue from chimeric mice 28 d after infection was fixed in buffered formalin, sectioned, and stained with hematoxylin and eosin. Panels A–C represent low power views of the lungs (magnification x50), and panels D–F represent high power views of the lesions (x400). A and C show small, discrete granulomas in WT and LTß-/- chimeric mice respectively, in contrast to the large necrotic lesions seen in the LT{alpha}-/- chimeric mice (B). D and F show the colocalization of macrophages and lymphocytes in the granulomas found in the WT and LTß-/- chimeras, respectively. This is in contrast to the large numbers of neutrophils and necrotic debris seen in the lesions of the LT{alpha}-/- chimeric mice (E).


  Discussion
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
References

Although the genes for LT{alpha}3 and TNF were identified at the same time (12), the functions of TNF have been more clearly defined than those for LT{alpha}3. LT{alpha}3 has been considered either as a mediator of inflammation or a functionally redundant form of TNF (20). Recently, with the advent of recombinant forms of LT{alpha}3, in vitro studies have delineated proinflammatory properties for LT{alpha}3 (21), although in vivo activity of LT{alpha}3, independent of TNF, has not been defined. This study demonstrates, for the first time, an essential function for secreted LT{alpha}3, but not membrane-bound LTß, in the control of pulmonary tuberculosis. TNF production was not impaired in the LT{alpha}- and LTß-deficient chimeric mice, with TNF mRNA being produced in the lungs of M. tuberculosis–infected LT{alpha}-/- and LTß-/- chimeric mice (Fig 3 C). Importantly, macrophages from LT{alpha}- and LTß-deficient mice demonstrated normal TNF secretion in response to both nonspecific activation and infection with M. tuberculosis (Fig 3 D). Moreover, LTß-deficient chimeric mice, produced in a similar fashion to LT{alpha}-/- chimeras, controlled M. tuberculosis infection in the same manner as chimeras reconstituted with WT bone marrow (Fig 2 A). Therefore, LT{alpha}3 is essential to control this chronic bacterial infection and acts independently of TNF, possibly through an additional receptor or mechanism. LT{alpha}3 has the potential to act at a number of steps in the host response to tuberculosis.

First, LT{alpha}3 deficiency may cause T cell dysfunction. However, T cell activation and IFN-{gamma} release was normal in all chimeric groups (Fig 1). Second, LT{alpha}3 may participate in the T cell–mediated activation of macrophage bactericidal mechanisms, such as the induction of inducible nitric oxide synthase (iNOS) and production of RNI. IFN-{gamma} synergizes with TNF (22) or LT{alpha}3 (23) to produce maximal activation of murine macrophages and the production of RNI, which have mycobactericidal activity both in vivo and in vitro (22). Both TNF and LT{alpha}3 can induce in vitro the nuclear translocation of nuclear factor (NF)-{kappa}B, resulting in the induction of iNOS gene transcription (24) (25). During M. tuberculosis infection, WT and LT{alpha}-/- chimeric mice demonstrated comparable levels of serum nitrite (Fig 3 A). Also, macrophages derived in vitro from LT{alpha}-/- and WT bone marrow produced similar levels of nitrite after nonspecific activation or infection with mycobacteria (Fig 3 B). Therefore, reduced capacity for macrophage activation, as measured indirectly by increased nitric oxide production, does not explain the susceptibility of LT{alpha}-/- chimeric mice to tuberculosis.

Third, LT{alpha}3 may contribute to the inflammatory component of the effector response to mycobacterial infection. A striking feature of the LT{alpha}-/- chimeric mice was the failure to develop a normal granulomatous response after mycobacterial infection. Containment of M. tuberculosis infection in the lungs requires the recruitment of CD4+ and CD8+ T cells across the pulmonary endothelium, leukocyte migration through the infected tissues, and the colocalization of macrophages and lymphocytes to form granulomas. LT{alpha}-/- and WT chimeras displayed equivalent accumulation of T cells in the lungs (Table 1), and these cells showed similar patterns of activation/memory marker expression (data not shown) and IFN-{gamma} production (Fig 1). In the LT{alpha}-/- chimeras, however, the lymphocytes accumulated in the perivascular and peribronchial regions of the lung and failed to migrate into the infected tissues. As a result, the well defined granulomas evident in WT chimeras were replaced by large accumulations of neutrophils and necrotic material. These changes in cell migration and granuloma formation in LT{alpha}-/- chimeric mice may relate to the recently described in vitro proinflammatory activities of LT{alpha}3. Recombinant murine (rm)LT{alpha}3 induced the expression of the cell adhesion molecules vascular cell adhesion molecule-1, intercellular adhesion molecule-1, E-selectin, and mucosal addressin cell adhesion molecule on endothelial cells in vitro (26). Furthermore, rmLT{alpha}3 induces the expression of T cell and monocyte attracting chemokines RANTES (regulated upon activation, normal T cell expressed and secreted), IFN-{gamma}–inducible protein-10, and monocyte chemoattractant protein-1 (26). Therefore, LT{alpha}3 has the potential to regulate the chemotactic signals that organize the cells into a mature granuloma, even though it is not a chemoattractant itself. As few studies into the chemokine-producing activity of LT{alpha}3 have been undertaken, it is possible that LT{alpha}3 may induce as yet unidentified chemokines and cytokines. Interestingly, LT{alpha} deficiency did not affect the acute cellular inflammation in the brain during EAE (18). This may represent differences in the intensity and chronicity of the inflammatory response, which are stronger and more prolonged after aerosol tuberculosis than that occurring during EAE, in addition to differences in the responding cell types and the organ involved in the inflammatory response.

Another facet of the dysregulated inflammatory response was the marked increase in granulocytes in the lungs of LT{alpha}-/- compared with LTß-/- chimeric and WT chimeric control mice (Table 1). This contrasts with the mild influx of neutrophils that may have a beneficial role early after M. tuberculosis infection in normal mice (27). In other genetically deficient mice with increased susceptibility to M. tuberculosis, such as TNF-/- and IFN-{gamma}-/- mice, a similar large influx of neutrophils occurs (5) (28). The accumulation of activated neutrophils may contribute to the marked damage to the lungs during infection. Neutrophil migration and activation contributes to lung injury in acute respiratory distress syndrome patients (29). The oxidative products cause endothelial and epithelial cell injury, leading to increased protein permeability into alveoli and impaired lung function. The combination of tissue necrosis and the increased protein exudation in areas without tissue destruction contributed to the death of these mice.

In contrast to the absolute requirement for LT{alpha}3 to control pulmonary tuberculosis, chimeric mice deficient in only membrane-bound LTß were able to mount a normal granulomatous response and contained M. tuberculosis infection. A recent study in which the action of LTß was blocked with a LTßR–Ig fusion protein during M. bovis (BCG) infection, found a modest, two- to threefold increase in bacterial numbers (30). These modest effects contrast with the profound susceptibility of LT{alpha}-/- chimeras, which showed greater than 1,000-fold increases in bacterial loads (Fig 3). Furthermore, any effects of LTßR–Ig therapy may be due to the neutralization of not only LTß, but also the cytokine LIGHT, which also signals through LTßR (31).

LT{alpha}3 has been considered to mediate its activity through TNFRI and TNFRII. Nevertheless, TNF, which was expressed normally in the lungs of the LT{alpha}-/- chimeric mice (Fig 3 C), was unable to compensate for the lack of LT{alpha}3. Therefore, it is possible that LT{alpha}3 is signaling through an additional receptor. One possibility is the HVEM receptor, which has a wide tissue distribution being expressed predominantly on T cells, B cells, and monocytes (32). Signaling through HVEM not only induces activation of the transcription factors NF-{kappa}B and activator protein 1 (33) but also is thought to play a role in T cell activation (34). An alternate possibility is that LT{alpha}3 may be signaling through the same receptors as TNF, but the timing and site of production of LT{alpha}3 may be different to that for TNF. Although T cells, which are the major source of LT{alpha}3, are also able to produce TNF, the relative importance of T cell–derived TNF, as compared with macrophage-derived TNF, in the immune response to tuberculosis is unclear. In summary, this model of chimeric mice deficient in individual members of the TNF/LT family of cytokines has identified an independent function for LT{alpha}3 in the host control of aerosol tuberculosis and will permit the further dissection of the mode of action of LT{alpha}3.


  Acknowledgements
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
References

This study was funded by the National Health and Medical Research Council of Australia. The support of the New South Wales Health Department through its research and development infrastructure grants program is gratefully acknowledged. D. Roach is a recipient of a University of Sydney Postgraduate Award.

Submitted: 5 July 2000
Revised: 8 November 2000
Accepted: 20 November 2000


  References
Top
Abstract
Introduction
Materials and Methods
Results
Discussion
Acknowledgements
References

  1. Schaible, U.E., Collins, H.L., and Kaufmann, S.H. 1999. Confrontation between intracellular bacteria and the immune system. Adv. Immunol. 71:267-377[Medline].

  2. Feng, C.G., Bean, A.G.D., Hooi, H., Briscoe, H., and Britton, W.J. 1999. Increase in gamma interferon-secreting CD8+ T cell, as well as CD4+, T cells in lungs following aerosol infection with Mycobacterium tuberculosis. Infect. Immun. 67:3242-3247[Abstract/Free Full Text].

  3. Flynn, J.L., Chan, J., Triebold, K.J., Dalton, D.K., Stewart, T.A., and Bloom, B.R. 1993. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. J. Exp. Med. 178:2249-2254[Abstract].

  4. Flesch, I.E., and Kaufmann, S.H. 1991. Mechanisms involved in mycobacterial growth inhibition by gamma interferon-activated bone marrow macrophages: role of reactive nitrogen intermediates. Infect. Immun. 59:3213-3218[Medline].

  5. Bean, A.G.D., Roach, D.R., Briscoe, H., France, M.P., Korner, H., Sedgwick, J.D., and Britton, W.J. 1999. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin. J. Immunol. 162:3504-3511[Abstract/Free Full Text].

  6. Korner, H., and Sedgwick, J.D. 1996. Tumour necrosis factor and lymphotoxin: molecular aspects and role in tissue-specific autoimmunity. Immunol. Cell Biol. 74:465-472[Medline].

  7. Hochman, P.S., Majeau, G.R., Mackay, F., and Browning, J.L. 1996. Proinflammatory responses are efficiently induced by homotrimeric but not heterotrimeric lymphotoxin ligands. J. Inflamm. 46:220-234.

  8. Bazzoni, F., and Beutler, B. 1996. The tumor necrosis factor ligand and receptor families. N. Engl. J. Med. 334:1717-1725[Free Full Text].

  9. Mauri, D.N., Ebner, R., Montgomery, R.I., Kochel, K.D., Cheung, T.C., Yu, G.L., Ruben, S., Murphy, M., Eisenberg, R.J., and Cohen, G.H. et al. 1998. Light, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity. 8:21-30[Medline].

  10. Ware, C.F., Crowe, P.D., Grayson, M.H., Androlewicz, M.J., and Browning, J.L. 1992. Expression of surface lymphotoxin and tumor necrosis factor on activated T, B, and natural killer cells. J. Immunol. 149:3881-3888[Abstract/Free Full Text].

  11. Loetscher, H., Gentz, R., Zulauf, M., Lustig, A., Tabuchi, H., Schlaeger, E.J., Brockhaus, M., Gallati, H., Manneberg, M., and Lesslauer, W. 1991. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity. J. Biol. Chem. 266:18324-18329[Abstract/Free Full Text].

  12. Pennica, D., Nedwin, G.E., Hayflick, J.S., Seeburg, P.H., Derynck, R., Palladino, M.A., Kohr, W.J., Aggarwal, B.B., and Goeddel, D.V. 1984. Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature. 312:724-729[Medline].

  13. Browning, J.L., Dougas, I., Ngam-ek, A., Bourdon, P.R., Ehrenfels, B.N., Miatkowski, K., Zafari, M., Yampaglia, A.M., Lawton, P., and Meier, W. 1995. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. J. Immunol. 154:33-46[Abstract/Free Full Text].

  14. Crowe, P.D., VanArsdale, T.L., Walter, B.N., Ware, C.F., Hession, C., Ehrenfels, B., Browning, J.L., Din, W.S., Goodwin, R.G., and Smith, C.A. 1994. A lymphotoxin-beta-specific receptor. Science. 264:707-710[Medline].

  15. Rennert, P.D., James, D., Mackay, F., Browning, J.L., and Hochman, P.S. 1998. Lymph node genesis is induced by signaling through the lymphotoxin beta receptor. Immunity. 9:71-79[Medline].

  16. Sacca, R., Cuff, C.A., Lesslauer, W., and Ruddle, N.H. 1998. Differential activities of secreted lymphotoxin-alpha(3) and membrane lymphotoxin-alpha(1)beta(2) in lymphotoxin-induced inflammation—critical role of TNF receptor 1 signalling. J. Immunol. 160:485-491[Abstract/Free Full Text].

  17. Riminton, D.S., Korner, H., Strickland, D.H., Lemckert, F.A., Pollard, J.D., and Sedgwick, J.D. 1998. Challenging cytokine redundancy: inflammatory cell movement and clinical course of experimental autoimmune encephalomyelitis are normal in lymphotoxin-deficient, but not tumor necrosis factor–deficient mice. J. Exp. Med. 87:1517-1526.

  18. Ngo, V.N., Korner, H., Gunn, M.D., Schmidt, K.N., Riminton, D.S., Cooper, M.D., Browning, J.L., Sedgwick, J.D., and Cyster, J.G. 1999. Lymphotoxin {alpha}/ß and tumor necrosis factor are required for stromal cell expression of homing chemokines in B and T cell areas of the spleen. J. Exp. Med. 189:403-412[Abstract/Free Full Text].

  19. Green, S.J., Mellouk, S., Hoffman, S.L., Meltzer, M.S., and Nacy, C.A. 1990. Cellular mechanisms of nonspecific immunity to intracellular infection: cytokine-induced synthesis of toxic nitrogen oxides from L-arginine by macrophages and hepatocytes. Immunol. Lett. 25:15-19[Medline].

  20. Mackay, F., Bourdon, P.R., Griffiths, D.A., Lawton, P., Zafari, M., Sizing, I.D., Miatkowski, K., Ngamek, A., Benjamin, C.D., and Hession, C. et al. 1997. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha-beta complexes. J. Immunol. 159:3299-3310[Abstract].

  21. Cuff, C.A., Schwartz, J., Bergman, C.M., Russell, K.S., Bender, J.R., and Ruddle, N.H. 1998. Lymphotoxin alpha 3 induces chemokines and adhesion molecules: Insight into the role of LT alpha in inflammation and lymphoid organ development. J. Immunol. 161:6853-6860[Abstract/Free Full Text].

  22. Chan, J., Xing, Y., Magliozzo, R.S., and Bloom, B.R. 1992. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages. J. Exp. Med. 175:1111-1122[Abstract].

  23. Ding, A.H., Nathan, C.F., and Stuehr, D.J. 1988. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141:2407-2412[Abstract/Free Full Text].

  24. Flesch, I.E., and Kaufmann, S.H. 1990. Activation of tuberculostatic macrophage functions by gamma interferon, interleukin-4, and tumor necrosis factor. Infect. Immun. 58:2675-2677[Medline].

  25. Matsushima, H., Shirai, M., Ouchi, K., Yamashita, K., Kakutani, T., Furukawa, S., and Nakazawa, T. 1999. Lymphotoxin inhibits Chlamydia pneumoniae growth in HEp-2 cells. Infect. Immun. 67:3175-3179[Abstract/Free Full Text].

  26. Cuff, C.A., Sacca, R., and Ruddle, N.H. 1999. Differential induction of adhesion molecule and chemokine expression by LT alpha 3 and LT alpha beta in inflammation elucidates potential mechanisms of mesenteric and peripheral lymph node development. J. Immunol. 162:5965-5972[Abstract/Free Full Text].

  27. Pedrosa, J., Saunders, B.M., Appelberg, R., Orme, I.M., Silva, M.T., and Cooper, A.M. 2000. Neutrophils play a protective nonphagocytic role in systemic Mycobacterium tuberculosis infection of mice. Infect. Immun. 68:577-583[Abstract/Free Full Text].

  28. Cooper, A.M., Dalton, D.K., Stewart, T.A., Griffin, J.P., Russell, D.G., and Orme, I.M. 1993. Disseminated tuberculosis in interferon {gamma} gene-disrupted mice. J. Exp. Med. 178:2243-2247[Abstract].

  29. Martin, T.R. 1997. Leukocyte migration and activation in the lungs. Eur. Resp. J. 10:770-771[Free Full Text].

  30. Lucas, R., Tacchini-Cottier, F., Guler, R., Vesin, D., Jemelin, S., Olleros, M.L., Marchal, G., Browning, J.L., Vassalli, P., and Garcia, I. 1999. A role for lymphotoxin beta receptor in host defense against Mycobacterium bovis BCG infection. Eur. J. Immunol. 29:4002-4010[Medline].

  31. Zhai, Y.F., Guo, R.B., Hsu, T.L., Yu, G.L., Ni, J., Kwon, B.S., Jiang, G.W., Lu, J.M., Tan, J., and Ugustus, M. et al. 1998. Light, a novel ligand for lymphotoxin beta receptor and Tr2/Hvem induces apoptosis and suppresses in vivo tumor formation via gene transfer. J. Clin. Invest. 102:1142-1151[Abstract/Free Full Text].

  32. Kwon, B.S., Tan, K.B., Ni, J., Oh, K.O., Lee, Z.H., Kim, K.K., Kim, Y.J., Wang, S., Gentz, R., and Yu, G.L. et al. 1997. A newly identified member of the tumor necrosis factor receptor superfamily with a wide tissue distribution and involvement in lymphocyte activation. J. Biol. Chem. 272:14272-14276[Abstract/Free Full Text].

  33. Marsters, S.A., Ayres, T.M., Skubatch, M., Gray, C.L., Rothe, M., and Ashkenazi, A. 1997. Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J. Biol. Chem. 272:14029-14032[Abstract/Free Full Text].

  34. Harrop, J.A., Reddy, M., Dede, K., Brigham-Burke, M., Lyn, S., Tan, K.B., Silverman, C., Eichman, C., DiPrinzio, R., and Spampanato, J. et al. 1998. Antibodies to TR2 (herpesvirus entry mediator), a new member of the TNF receptor superfamily, block T cell proliferation, expression of activation markers, and production of cytokines. J. Immunol. 161:1786-1794[Abstract/Free Full Text].